Transcript
Jad Abumrad (0:02)
Oh, wait, you're listening.
Robert Krulwich (0:03)
Okay.
Jad Abumrad (0:04)
All right. Okay.
Alex Honl (0:06)
All right. You're listening to Radiolab Radio Lab from wny.
Carl Zimmer (0:14)
See?
Jad Abumrad (0:15)
Yep.
Kevin Esvelt (0:19)
Let me tell you, there is nothing like the sheer elation of discovery. And I was thinking, you know, this. This is the end of malaria. This is the end of everything else. Mosquitoes spread, which. Wait a minute, you know, ticks spread Lyme disease. We can probably get rid of that, too.
Alex Honl (0:29)
I thought so. In the morning, you were like.
Soren Wheeler (0:31)
You were singing to the turtles in the park and.
Kevin Esvelt (0:34)
Pretty much. And I gave myself a full day of being who. And then I started thinking. But, but, but, but what if something goes wrong?
Jad Abumrad (0:47)
I'm Jad Abumrad.
Robert Krulwich (0:48)
I'm Robert Krulwich.
Jad Abumrad (0:50)
This is Radiolab, and the guy that you just heard is Kevin Esvelt. He is a scientist. He was talking to our producers, Soren Wheeler and Molly Webster, about crispr, which is a technology.
Robert Krulwich (1:00)
Actually. It's a new. It's a gene editing technology that can reshape life, actually.
Jad Abumrad (1:05)
Yeah. And we ended up doing an entire show about this.
Alex Honl (1:08)
Yeah. And we called it Antibodies, Part one.
Jad Abumrad (1:11)
I do remember that.
Alex Honl (1:12)
As if there was gonna be a part two.
Soren Wheeler (1:15)
Name that. It's like telling someone you got them a birthday present, but you haven't yet.
